Pirnabine
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Identifiers | |
---|---|
|
|
CAS Number | 68298-00-0 |
PubChem (CID) | 50137 |
ChemSpider | 45469 |
UNII | S3FHL03F60 Y |
Chemical and physical data | |
Formula | C19H24O3 |
Molar mass | 300.391 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Pirnabine (SP-304) is a synthetic cannabinoid receptor ligand, which was developed for the treatment of glaucoma.[1]
References[edit]
Receptor (ligands) |
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (modulators) |
|
||||||||||||||||||
Enzyme (modulators) |
|
||||||||||||||||||
Others |
|
||||||||||||||||||
|
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Pirnabine&oldid=728867735"